SC
Scienture Holdings, Inc.
SCNX · NASDAQ
$0.31 +1.13% (+$0.00)
1M -30.29%
Market Cap $15.0M
P/E Ratio -
Div. Yield -
ROE 0.12%
Bulios Fair Price
$0.42
34.0% upside
Current Price
$0.31
Undervalued Fair Value Overvalued
According to Bulios Fair Price, SCNX is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
4/9Valuation
50 /100
Fair P/B 0.00x
P/S 18.29x
EV/EBITDA N/A
Growth
22 /100
Declining Book val. growth 351.25%
Rev. growth 65.21%
FCF growth N/A
Profitability
11 /100
Weak Net margin 4,620.92%
Op. margin 1,671.08%
FCF margin 737,839.00%
Quality
1 /100
Poor ROE 0.12%
ROA 0.04%
Asset turnover 0.00x
Debt
69 /100
Low Current ratio 3.04x
Int. coverage -12.08x
Debt/Equity 0.17x
Stability
1 /100
Unstable Rev. volatility 175.64%
EPS volatility 171.24%
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about SCNX
Online
Sector
Healthcare
Industry
Medical - Pharmaceuticals
CEO
Shankar Hariharan
Employees
9
Headquarters
Commack
Upcoming events
12 NOV
Earnings
Upcoming earnings report